Cancer Immunology and Immunotherapy

Mansoor M. Amiji is the Distinguished Professor and Chairman of the Department of Pharmaceutical Sciences at the Bouvé College of Health Sciences at Northeastern University. Dr. Amiji has edited a number of books and is a frequently published author. His research focuses on the synthesis of novel polymeric materials for medical and pharmaceutical applications, drug delivery systems and nanomedical technologies, and his contributions in research advising, grant reviews for various organizations and editorial work for journals are invaluable. Dr. Lara Milane is Assistant Teaching Professor in Biotechnology at the Bouvé College of Health Sciences at Northeastern University. She is interested in Mitochondrial Medicine. She is working on developing nanomedicines for a range of diseases (cancer, neurodegenerative disease, aging) that manipulate mitochondria for therapeutic outcomes. Dr. Milane was trained as a National Cancer Institute/ National Science Foundation Nanomedicine Fellow at Northeastern University, Boston, MA. Dr. Milane is an intuitive cancer biologist with research interests in developing translational nanomedicines that exploit the hallmarks of cancer.

• 1. The hallmarks of cancer and immunology2. Innate and adaptive immunity in cancer3. Inflammation and cancer4. Novel immunotherapeutic approaches to cancer: Voltage-gated sodium channel expression in immune cells and tumors5. Immunoediting and cancer priming6. Metabolic reprogramming and immunity in cancer7. Epigenetic programming of the immune responses in cancer8. Cellular therapeutics in immuno-oncology9. T-cell engaging bispecific antibody therapy10. Role of microbiome in cancer immunotherapy11. STING pathway and modulation for cancer immunotherapy12. Oncolytic viruses in immunotherapy13. Comparison of therapeutic strategies for immuno-oncology14. Intrinsic and acquired cancer immunotherapy resistance15. Preclinical and clinical toxicity of immuno-oncology agents and mitigation strategies